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Commentary on: 
 
“Questioning an axiom: Better prognosis for Schizophrenia in the Developing World” 
Cohen et. al. 
In: Schizophrenia Bulletin 2007 
 
 
In the 1950s, 60s and 70s, the field of cross-cultural (or transcultural psychiatry) provided 
what was largely Euro American psychiatry with several useful alternatives.  Based on 
limited research it balanced the near hegemonic American and British research materials 
and conclusions with data from the non-Western world, and with new findings about 
established psychiatric disorders that challenged diagnoses, programs and treatments. 
Cultural psychiatry still provides those contributions, but psychiatry itself has changed.  
We are now in an era of global psychiatry, where psychiatrists from Asia, Latin America, 
and Africa are contributing numerous studies on mental illness and mental health care, 
and these are now becoming part of psychiatric science.  Not surprisingly, over the past 
few decades studies of depression, suicide, psychosis and substance abuse in a wide 
range of societies have greatly increased.  One outcome of that increase is that we now 
have a much more detailed and complex view of these conditions in different 
socioeconomic, cultural and political settings. 
 
The review by Cohen et al. needs to be understood in this context of globalization.  They 
show that the data about course and outcome of schizophrenia is much more complicated 
for all societies, but especially for poor and middle income societies. They conclude that 
one of the conclusions of the past -- -- namely that schizophrenia has a better outcome in 
those societies compared to rich nations -- -- needs to be reconsidered.  And they bring a 
substantial body of data to bear on that process of reassessment, along the way pointing 
to the deep processes of family responses, work conditions, stigma, and adult mortality, 
about which much more needs to be understood.  I am persuaded by their comments, and 
find their conclusion well reasoned and reasonable. 
 
Cohen has made a career of criticizing WHO studies of schizophrenia.  And many of his 
concerns are important.  Readers need to balance the questions he and his distinguished 
colleagues raise with the conclusions of the WHO studies’ authors.  Given that we don’t 
know the cause of schizophrenia, that many suspect it contains multiple distinctive 
conditions, that research on treatment has been controversial, and that the course of 
psychosis has been shown to be influenced by many factors, it is impressive to begin with 
that there is a strong cross-cultural hypothesis in the field.  This hypothesis and this 
article’s criticism have contributed, in my view, to move the field ahead conceptually and 
empirically. That there is still uncertainty, confusion and controversy is a sign of how 
very much more we need to learn. But let’s also celebrate how far we have come. What we now know about the course of schizophrenia appears to argue against any simple 
conclusion. The still dominant view in psychiatry that schizophrenia is a disorder of 
progressive, unrelenting deterioration is not supported by long term outcome studies, 
even in North America. The view that schizophrenia has a more favorable outcome in 
poorer societies now also appears less certain. And this should lead to a more complex 
and sophisticated appreciation both of the biosocial course of the group of psychotic 
conditions that constitutes schizophrenia and of the diverse research perspectives in 
psychiatry that wrestle with how to make context as important as condition in the 
understanding of outcome.  
 
This sense of progress in our cross-cultural understanding of mental illness can also be 
illustrated by other early formulations that have been proved inaccurate or inadequate. 
For example, when the first set of WHO studies concluded that outcome was better in 
low resource societies, it was proposed that those societies were more sociocentric than 
psychocentric industrialized societies and therefore outcome might reflect greater family 
and community support systems. Wrong. We have learned over the years that virtually all 
societies contain both strong interpersonal ties and individualistic orientations. While 
family connections may seem stronger in certain poor societies with powerful cultural 
supports for patriarchy, they have been shown to be as much a source of stress as support. 
The same holds for stigma. Stigma about serious mental illness seems to exist almost 
everywhere. Its sources and patterns may differ but its consequences for the mentally ill 
are terrible in rich and poor societies alike. Societies can not be categorized as high 
support or low stigma. The social processes involved in the course of chronic illness are 
no more easily stereotyped than ethnicity is. No one can believe today that all Chinese act 
one way; all Americans another. Intraethnic and intrasocietal diversity is large. And this 
means we need a more nuanced and complex modeling of social processes just as we 
require a more subtle and precise understanding of symptoms and syndromes. That 
recognition represents the kind of progress in cross-cultural psychiatric understanding 
that our improving understanding of course and outcome of schizophrenia also 
represents.  
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